Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Julien Riou

Showing results (21-30 of 47) with videos related to

Pageof 5
Sort By:
Environment International|March 27, 2025
Serum biomonitoring of per- and polyfluoroalkyl substances (PFASs) in the adult population of Switzerland: Results from the pilot phase of the Swiss health studyAlexandra Jaus, Céline Fragnière Rime, Julien Riou, et al.
Epidemiology and Infection|August 21, 2024
Surveillance of SARS-CoV-2 prevalence from repeated pooled testing: application to Swiss routine dataJulien Riou, Erik Studer, Anna Fesser, et al.
Journal of Clinical Epidemiology|February 22, 2022
Acquired HIV drug resistance mutations on first-line antiretroviral therapy in Southern Africa: Systematic review and Bayesian evidence synthesisAnthony Hauser, Fardo Goldstein, Martina L Reichmuth, et al.
Epidemics|November 29, 2022
Impact of cross-border-associated cases on the SARS-CoV-2 epidemic in Switzerland during summer 2020 and 2021Martina L Reichmuth, Emma B Hodcroft, Julien Riou, et al.
Elife|January 14, 2021
A mechanistic model for long-term immunological outcomes in South African HIV-infected children and adults receiving ARTEva Liliane Ujeneza, Wilfred Ndifon, Shobna Sawry, et al.
BMC Public Health|August 10, 2023
Socio-demographic characteristics associated with COVID-19 vaccination uptake in Switzerland: longitudinal analysis of the CoMix studyMartina L Reichmuth, Leonie Heron, Julien Riou, et al.
Plos Medicine|July 30, 2020
Estimation of SARS-CoV-2 mortality during the early stages of an epidemic: A modeling study in Hubei, China, and six regions in EuropeAnthony Hauser, Michel J Counotte, Charles C Margossian, et al.
BMC Infectious Diseases|October 8, 2021
Drivers of HIV-1 drug resistance to non-nucleoside reverse-transcriptase inhibitors (NNRTIs) in nine southern African countries: a modelling studyJulien Riou, Carole Dupont, Silvia Bertagnolio, et al.
Plos Computational Biology|June 25, 2019
Bridging the gap between HIV epidemiology and antiretroviral resistance evolution: Modelling the spread of resistance in South AfricaAnthony Hauser, Katharina Kusejko, Leigh F Johnson, et al.
BMC Pregnancy and Childbirth|March 26, 2024
Health of singleton neonates in Switzerland through time and crises: a cross-sectional study at the population level, 2007-2022Mathilde Le Vu, Katarina L Matthes, Marek Brabec, et al.
Pageof 5

Showing results (21-30 of 47) with videos related to

Sort By:
Pageof 5
Environment International|March 27, 2025
Serum biomonitoring of per- and polyfluoroalkyl substances (PFASs) in the adult population of Switzerland: Results from the pilot phase of the Swiss health studyAlexandra Jaus, Céline Fragnière Rime, Julien Riou, et al.
Epidemiology and Infection|August 21, 2024
Surveillance of SARS-CoV-2 prevalence from repeated pooled testing: application to Swiss routine dataJulien Riou, Erik Studer, Anna Fesser, et al.
Journal of Clinical Epidemiology|February 22, 2022
Acquired HIV drug resistance mutations on first-line antiretroviral therapy in Southern Africa: Systematic review and Bayesian evidence synthesisAnthony Hauser, Fardo Goldstein, Martina L Reichmuth, et al.
Epidemics|November 29, 2022
Impact of cross-border-associated cases on the SARS-CoV-2 epidemic in Switzerland during summer 2020 and 2021Martina L Reichmuth, Emma B Hodcroft, Julien Riou, et al.
Elife|January 14, 2021
A mechanistic model for long-term immunological outcomes in South African HIV-infected children and adults receiving ARTEva Liliane Ujeneza, Wilfred Ndifon, Shobna Sawry, et al.
BMC Public Health|August 10, 2023
Socio-demographic characteristics associated with COVID-19 vaccination uptake in Switzerland: longitudinal analysis of the CoMix studyMartina L Reichmuth, Leonie Heron, Julien Riou, et al.
Plos Medicine|July 30, 2020
Estimation of SARS-CoV-2 mortality during the early stages of an epidemic: A modeling study in Hubei, China, and six regions in EuropeAnthony Hauser, Michel J Counotte, Charles C Margossian, et al.
BMC Infectious Diseases|October 8, 2021
Drivers of HIV-1 drug resistance to non-nucleoside reverse-transcriptase inhibitors (NNRTIs) in nine southern African countries: a modelling studyJulien Riou, Carole Dupont, Silvia Bertagnolio, et al.
Plos Computational Biology|June 25, 2019
Bridging the gap between HIV epidemiology and antiretroviral resistance evolution: Modelling the spread of resistance in South AfricaAnthony Hauser, Katharina Kusejko, Leigh F Johnson, et al.
BMC Pregnancy and Childbirth|March 26, 2024
Health of singleton neonates in Switzerland through time and crises: a cross-sectional study at the population level, 2007-2022Mathilde Le Vu, Katarina L Matthes, Marek Brabec, et al.
Pageof 5